Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paul Demchak"'
Autor:
John D. Tamerius, James W. Mier, Gloria Vachino, Michael B. Atkins, Paul Demchak, Jeffrey A. Gelfand
Publikováno v:
Blood. 78:2505-2513
Plasma samples from cancer patients undergoing immunotherapy with high- dose recombinant interleukin-2 (IL-2) were obtained over a 5-day course of treatment and assayed by radioimmunoassay or enzyme-linked immunosorbent assay for the complement degra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86fd34b8d5f6280d25ca179c234d0d9f
https://doi.org/10.1182/blood.v78.10.2505.2505
https://doi.org/10.1182/blood.v78.10.2505.2505
Autor:
James H. Doroshow, Mario Sznol, Geoffrey R. Weiss, Paul Demchak, Michael J. Hawkins, Frederick R. Aronson, David H. Boldt, Geralyn Caliendo, Kathleen M. Grima, M H Bar, James W. Mier, Ellen R. Gaynor, Richard I. Fisher, Kim Margolin
Publikováno v:
JNCI Journal of the National Cancer Institute. 82:1397-1402
The current study was undertaken to determine the maximum tolerated dose of recombinant interleukin-2 (rIL-2) that could be administered as a continuous infusion in conjunction with autologous lymphokine-activated killer (LAK) cells. All 55 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405ef3e6f84b0b8a5646178e017f2869
https://doi.org/10.1093/jnci/82.17.1397
https://doi.org/10.1093/jnci/82.17.1397
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.